A meta-analysis indicated a significant association of the IL-6 gene rs1800795 and rs1800796 polymorphism with an overall elevated risk of prostate cancer based on the information collected from 118 GWAS studies consisting of 50,053 cases and 65,204 control samples (33). The gene discussed is IL6; the disease is prostate carcinoma.